Tingyuan Yang
Shanghai, 200237, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Design and development of novel EGFR inhibitors spanning all subgroups of EGFR mutations in non-small cell lung cancer.
Journal: Innovation (Cambridge (Mass.))
Published: May 22, 2025
Targeting DHODH reveals therapeutic opportunities in ATRA-resistant acute promyelocytic leukemia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 20, 2023
Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors.
Journal: European journal of medicinal chemistry
Published: June 18, 2022
Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis.
Journal: Acta pharmaceutica Sinica. B
Published: July 01, 2020
Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation.
Journal: Bioorganic & medicinal chemistry letters
Published: April 16, 2020
Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2.
Journal: Bioorganic & medicinal chemistry letters
Published: March 18, 2019
Self-Assembly of a Monochromophore-Based Polymer Enables Unprecedented Ratiometric Tracing of Hypoxia.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 04, 2018
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.
Journal: Journal of medicinal chemistry
Published: June 16, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026